Search research articles
Contact Us
Filters
Showing results (1-10 of 259) with videos related to
Page
of 26
Sort By:
European Heart Journal
|
October 8, 2021
Immune checkpoint inhibitors and cardiovascular events among patients with cancer: a window into the critical role of the immune system in cardiovascular biology
Lavanya Kondapalli, Tomas G Neilan
Nature Reviews. Cardiology
|
December 21, 2022
Immune checkpoint inhibitors: acute and chronic cardiovascular complications
Kiranbir Josan, Tomas G Neilan
JACC. Cardiovascular Imaging
|
March 12, 2016
The Authors Reply
Tomas G Neilan, Raymond Kwong
JACC. Cardiovascular Imaging
|
May 23, 2021
Tissue Characterization With CMR and Adverse Cardiac Events Among Persons With HIV
Ahmed Tawakol, Tomas G Neilan
The Oncologist
|
May 27, 2018
Immune Checkpoint Inhibitor-Associated Myocarditis
Sarju Ganatra, Tomas G Neilan
Revista Espanola De Cardiologia
|
September 30, 2010
Characterizing post-myocardial infarction microvascular obstruction by ECG: we could learn more from cardiac magnetic resonance imaging
Raymond Y Kwong, Tomas G Neilan
Journal of Cardiovascular Translational Research
|
May 6, 2020
COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection
Hasan K Siddiqi, Tomas G Neilan
JACC. Clinical Electrophysiology
|
May 16, 2018
Cardiovascular Outcomes in Anthracycline-Related Cardiomyopathy: When a p Value of >0.05 Is a Good Outcome!
Michael G Fradley, Tomas G Neilan
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
June 30, 2009
Endurance exercise and the heart: multiple benefits but many unanswered questions
Tomas G Neilan, Malissa J Wood
Journal of the American College of Cardiology
|
February 25, 2014
Reply: prognostic value of myocardial scar in atrial fibrillation
Tomas G Neilan, Raymond Y Kwong
Page
of 26
Search research articles
Search
Showing results (1-10 of 259) with videos related to
Sort By:
Page
of 26
European Heart Journal
|
October 8, 2021
Immune checkpoint inhibitors and cardiovascular events among patients with cancer: a window into the critical role of the immune system in cardiovascular biology
Lavanya Kondapalli, Tomas G Neilan
Nature Reviews. Cardiology
|
December 21, 2022
Immune checkpoint inhibitors: acute and chronic cardiovascular complications
Kiranbir Josan, Tomas G Neilan
JACC. Cardiovascular Imaging
|
March 12, 2016
The Authors Reply
Tomas G Neilan, Raymond Kwong
JACC. Cardiovascular Imaging
|
May 23, 2021
Tissue Characterization With CMR and Adverse Cardiac Events Among Persons With HIV
Ahmed Tawakol, Tomas G Neilan
The Oncologist
|
May 27, 2018
Immune Checkpoint Inhibitor-Associated Myocarditis
Sarju Ganatra, Tomas G Neilan
Revista Espanola De Cardiologia
|
September 30, 2010
Characterizing post-myocardial infarction microvascular obstruction by ECG: we could learn more from cardiac magnetic resonance imaging
Raymond Y Kwong, Tomas G Neilan
Journal of Cardiovascular Translational Research
|
May 6, 2020
COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection
Hasan K Siddiqi, Tomas G Neilan
JACC. Clinical Electrophysiology
|
May 16, 2018
Cardiovascular Outcomes in Anthracycline-Related Cardiomyopathy: When a p Value of >0.05 Is a Good Outcome!
Michael G Fradley, Tomas G Neilan
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
June 30, 2009
Endurance exercise and the heart: multiple benefits but many unanswered questions
Tomas G Neilan, Malissa J Wood
Journal of the American College of Cardiology
|
February 25, 2014
Reply: prognostic value of myocardial scar in atrial fibrillation
Tomas G Neilan, Raymond Y Kwong
Page
of 26